Compositions And Methods For Treating Purpura


The full document isn't yet available to us from the patent office.


Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Pre-ferred compositions comprise an ± adrenergic receptor agonist selected from selective ± 1 adrenergic receptor agonist, selective ± 2 adrenergic receptor agonist, non-selective ± 1 / ± 2 adrenergic receptor agonist, agents with ± 2 adrenergic receptor agonist activity and combinations thereof, in a pharmaceutically acceptable carrier in order to treat and improve the cosmetic appearance of hemorrhagic (purpuric) lesions in the skin.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Dec 31, 2014
  • Application: Nov 17, 2008
    EP EP 14170999 A
  • Priority: Nov 17, 2008
    EP EP 08850846 A
  • Priority: Nov 16, 2007
    US US 98856407 P

Sign in to the Lens